UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of ~~February~~April 2023

Commission File Number: 001-39810

IDEX Biometrics ASA

(Translation of registrant’s name into English)

Dronning Eufemias gate 16

Oslo, Norway

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: ☒ Form 20-F ☐ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

INCORPORATION BY REFERENCE

This Report on Form 6-K and Exhibits 99.2 and 99.3 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statement on Form F-3 (File No. 333-250186) and registration statements on Form S-8 (File Nos. 333-254083, 333-259210 and 333-265481) of IDEX Biometrics ASA (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

Grant of Incentive Subscription Rights

On February 22, 2023, IDEX Biometrics ASA (the “Company”) issued a press release announcing the grant of incentive subscription rights pursuant to the Company’s 2022 Incentive Subscription Rights Plan, including grants to primary insiders of the Company. A copy of this press release is attached to this Form 6-K as Exhibit 99.1.

Other Events

On ~~February~~April 2226, 2023, IDEX Biometrics ASA (the “Company”) published its ~~Interim~~Norwegian Annual Report ~~for~~and ~~the~~Executive ~~fourth~~Remuneration ~~quarter~~Report offor ~~2022~~the ~~and~~year ~~issued~~ended aDecember ~~press~~31, ~~release providing commentary thereon~~2022. The ~~Interim~~Norwegian Annual Report and ~~press~~Executive ~~release~~Remuneration Report are ~~attached~~furnished toherewith ~~this form 6-K~~ as Exhibits 99.21 and 99.32, respectively, to this Report on Form 6-K.

OnThe ~~February~~information ~~22,~~with ~~2023,~~respect ~~the~~to ~~Company~~Other ~~also~~Events ~~published~~contained anin ~~updated~~this ~~Company~~Report ~~Presentation~~on Form 6-K and Exhibits 99.1 and 99.2 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the ~~fourth~~Securities ~~quarter~~Exchange Act of ~~2022.~~1934, ~~The~~as ~~Company~~amended, ~~Presentation~~or isincorporated ~~attached~~by toreference ~~this~~in ~~form~~any ~~6-K~~filing under the Securities Act of 1933, as ~~Exhibit~~amended, 99unless expressly set forth by specific reference in such a filing.4.

The information with respect to the Grant of Incentive Subscription Rights and Company Presentation contained in this Report on Form 6-K and Exhibits 99.1 and 99.4 to this Report on Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, unless expressly set forth by specific reference in such a filing.

RISK FACTORS

Our business faces significant risks. You should carefully consider all of the information set forth in this Report on Form 6-K and in our other filings with the United States Securities and Exchange Commission (the “SEC”), including the risk factors set forth in our Annual Report on Form 20-F for the year ended December 31, ~~2021~~2022 filed with the SEC on April 2926, ~~2022~~2023. Our business, financial condition, results of operations and growth prospects could be materially adversely affected by any of these risks. This report also contains forward-looking statements that involve risks and uncertainties. Our results could materially differ from those anticipated in these forward-looking statements, as a result of certain factors including the risks described in our Annual Report and our other SEC filings.

EXHIBIT LIST

Exhibit	~~Description~~	Description
99.1	~~Press release dated February 21, 2023 announcing the grant of incentive subscription rights~~	Annual Report for the year ended December 31, 2022
99.2	~~Interim Report for the fourth quarter of 2022~~	Executive Remuneration Report for the year ended December 31, 2022
99.3	Press release dated February 22, 2023 announcing the Interim Report
99.4	Company Presentation for the fourth quarter of 2022

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

IDEX BIOMETRICS ASA

Date: February 24, 2023

/s/ Vincent Graziani

Date: April 27, 2023

/s/ Vincent Graziani

Name: Vincent Graziani

Title: Chief Executive Officer

Filing Compare · IDEX Biometrics ASA